GPC3 and hepatocellular carcinoma: It should also be noted that the presence of the Gpc3 marker, which can be used to distinguish early-stage HCC from dysplastic nodules [28], can already be detected in the majority of transformed hepatocyte colonies at the earlier examination time point, 5 weeks post-treatment (Fig. 3a).